ASCENTAGE
"ASCENTAGE" is a word mark owned by Ascentage Pharma (Suzhou) Co., Ltd., filed at the CIPO on July 18, 2025. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).
- Status
- Filed
- Since April 14, 2026
- Filed
- July 18, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 2412431
- Registration no.
- Not yet
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 1 class
Who owns ASCENTAGE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Ascentage Pharma (Suzhou) Co., Ltd.
China
Representative
CPST Intellectual Property Inc.
CPST Intellectual Property Inc.
What the mark covers
The products and services ASCENTAGE is filed for, grouped by Nice class.
Chemical preparations for medical purposes for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antibiotics; Injectable medicines for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; medicine in tablet form for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; hemorrhoidal suppositories, laxative suppositories, and vaginal suppositories for the prevention and treatment of infections; medicated plasters; diagnostic preparations for medical purposes namely for use in cancer treatments; diagnostic biomarker reagents for medical purposes; Oil solutions for or use in the treatment of cancer and tumors; mineral food supplements; nutritional supplements for use in the treatment of cancer and tumors; Medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; bacterial poisons; Pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; Chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes for use in the treatment of cancer and tumors; Gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; solutions for contact lenses; media for bacteriological cultures; Depuratives for use in the treatment of cancer and tumors; veterinary preparations for use in the treatment of cancer and tumors; pesticides; sanitary napkins; dental abrasives; diapers for pets.
What has happened so far
Steps recorded by the CIPO, newest first.
- Extension of Time; Request Letter Date: 2026/10/01
- Examiner's First Report
- Search Recorded
- Pre-Assessment Letter Sent; Goods or Services Not Acceptable
- Formalized
- Created
- Filed
About ASCENTAGE
Who owns the trademark "ASCENTAGE"?
The CIPO trademark "ASCENTAGE" (application 2412431) is owned by Ascentage Pharma (Suzhou) Co., Ltd.
What is the status of "ASCENTAGE"?
Its status at the CIPO is: filed.
Get this data via the API
Everything on this page comes from the Signa API. Pull ASCENTAGE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deda7-7f1e-773b-874f-e02d81dc42bb
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deda7-7f1e-773b-874f-e02d81dc42bb",
"object": "trademark",
"mark_text": "ASCENTAGE",
"status": {
"primary": "pending",
"stage": "filed"
},
"office_code": "CA",
"application_number": "2412431",
"filing_date": "2025-07-18",
"nice_classes": [
5
],
"owners": [
{
"name": "ASCENTAGE PHARMA (SUZHOU) CO., LTD.",
"entity_id": "ent_019eb7d1-fa6d-74ef-aad1-d36b9d2a9480"
}
]
}